Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
10%
Aggressive Treatment
16%
ANCA-associated Vasculitis
50%
Area under the ROC Curve
12%
Autoimmune Arthritis
16%
Botulism
10%
Brain Magnetic Resonance Imaging
16%
C. Difficile
25%
Chronic Diarrhea
50%
Clinical Infectious Diseases
50%
Clinical Presentation
16%
Clostridium Difficile Infection
50%
Creatine Kinase
16%
Deep Gray Matter
16%
Diagnostic Stewardship
66%
Epidemiology
50%
Foodborne Botulism
100%
Foodborne Disease
50%
Granulomatosis with Polyangiitis
50%
Healthcare
50%
Human Experience
50%
Illness Experience
50%
Inappropriate Testing
16%
Infection Rate
25%
Innovation Outcomes
50%
Innovation Quality
50%
Inpatient Treatment
50%
Intervention Bundle
16%
Low Risk
12%
Mayo Clinic
50%
Meta-analysis
50%
Microscopic Colitis
50%
Multi-organ
16%
Multiple Organ Failure
16%
Muscle Pain
16%
Muscular Fibers
16%
Musculoskeletal Manifestations
16%
Myositis
33%
Negative Predictive Value
18%
Presenting Symptoms
16%
Prompt Treatment
16%
Proximal muscle Weakness
50%
Quality Improvement Initiatives
50%
Quality Outcomes
50%
Scoring System
50%
Serology
16%
Toxin Exposure
10%
Toxin-antitoxin
100%
Vulnerable Patients
50%
Waterborne Diseases
50%
Medicine and Dentistry
Antitoxin
66%
Biopsy Technique
25%
Body Mass Index
6%
Botulinum Antiserum
5%
Botulism
66%
Chronic Diarrhea
50%
Cohort Effect
16%
Colon Biopsy
6%
Colonoscopy
12%
Diarrhea
6%
Disease Course
5%
Diseases
60%
Education
8%
Electronic Health Record
8%
Health Care
50%
Health Care Cost
12%
Independent Reviewer
5%
Infection
50%
Infectious Disease
16%
Intensive Care
10%
Logistic Regression Analysis
6%
Meta-Analysis
50%
Microscopic Colitis
50%
Nonsteroid Antiinflammatory Agent
6%
Noradrenalin
6%
Odds Ratio
10%
Patient Characteristics
5%
Patient Population
16%
Patient Safety
8%
Quality Improvement
50%
Respiratory Failure
5%
Retrospective Study
6%
Scoring System
50%
Selective Serotonin Reuptake Inhibitor
6%
Serotonin
6%
Systematic Review
50%
Therapeutic Agent
5%
Translating (Language)
6%